Abstract
Protein mobility, chromatin movement and the formation of molecular assemblies in the cell nucleus have, until fairly recently, been viewed in a pseudo-static light, even though the dynamics of other cellular regions have been partly, or wholly understood for a number of years. The new science that has recently emerged on nuclear kinetics reveals a nucleus that has mobile proteins, dynamic intra-nuclear compartments and chromatin that is far from being static. This new knowledge has given scientists a deeper understanding of transcription, translation and the cell cycle. With these fundamentals of nuclear operation, has come a greater understanding of genetics and genetic diseases – so much so that, by way of example, diseases of chromatin have as a category, made significant advances. Whilst certain questions relating to protein mobility, chromatin movement and the formation of molecular assemblies have been answered, many key questions still remain. Those remaining questions have now started to be answered by technological developments. This review marshals the latest scientific evidence on the molecular kinetics of the nucleus that has arisen from a number of recent, elegant experiments.
Keywords: Dynamics, protein dynamics, chromatin dynamics, residence time, surface profile
Current Chemical Biology
Title: Molecular Kinetics and Targeting Within the Nucleus
Volume: 2 Issue: 3
Author(s): Christopher M. Wood
Affiliation:
Keywords: Dynamics, protein dynamics, chromatin dynamics, residence time, surface profile
Abstract: Protein mobility, chromatin movement and the formation of molecular assemblies in the cell nucleus have, until fairly recently, been viewed in a pseudo-static light, even though the dynamics of other cellular regions have been partly, or wholly understood for a number of years. The new science that has recently emerged on nuclear kinetics reveals a nucleus that has mobile proteins, dynamic intra-nuclear compartments and chromatin that is far from being static. This new knowledge has given scientists a deeper understanding of transcription, translation and the cell cycle. With these fundamentals of nuclear operation, has come a greater understanding of genetics and genetic diseases – so much so that, by way of example, diseases of chromatin have as a category, made significant advances. Whilst certain questions relating to protein mobility, chromatin movement and the formation of molecular assemblies have been answered, many key questions still remain. Those remaining questions have now started to be answered by technological developments. This review marshals the latest scientific evidence on the molecular kinetics of the nucleus that has arisen from a number of recent, elegant experiments.
Export Options
About this article
Cite this article as:
Wood M. Christopher, Molecular Kinetics and Targeting Within the Nucleus, Current Chemical Biology 2008; 2 (3) . https://dx.doi.org/10.2174/2212796810802030229
DOI https://dx.doi.org/10.2174/2212796810802030229 |
Print ISSN 2212-7968 |
Publisher Name Bentham Science Publisher |
Online ISSN 1872-3136 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Water and Ion Channels: Crucial in the Initiation and Progression of Apoptosis in Central Nervous System?
Current Neuropharmacology The Role of Tregs in Cancer: Foxp3 as a Putative Target for Therapy
Current Signal Transduction Therapy Drug Transport Across the Blood-Brain Barrier and the Impact of Breast Cancer Resistance Protein (ABCG2)
Current Topics in Medicinal Chemistry Threes Company: Regulation of Cell Fate by Statins
Current Drug Targets - Cardiovascular & Hematological Disorders Cancer Stem Cells – Are Surface Markers Alone Sufficient?
Current Stem Cell Research & Therapy HSP60 as a Drug Target
Current Pharmaceutical Design Anti-Proliferative Effects of Novel Glyco-Lipid-Arsenicals (III) on MCF-7 Human Breast Cancer Cells
Medicinal Chemistry Development of DNA Topoisomerase II-Mediated Anticancer Agents, 3-(9- Acridinylamino)-5-hydroxymethylanilines (AHMAs) and Related Compounds
Current Medicinal Chemistry Novel Concepts in the Development of Platinum Antitumour Drugs: An Update
Medicinal Chemistry Reviews - Online (Discontinued) Pleiotropic Effect of Mahanine and Girinimbine Analogs: Anticancer Mechanism and its Therapeutic Versatility
Anti-Cancer Agents in Medicinal Chemistry Significance of Prion and Prion-Like Proteins in Cancer Development, Progression and Multi-Drug Resistance
Current Cancer Drug Targets The Challenge of Exploiting ABCG2 in the Clinic
Current Pharmaceutical Biotechnology Synthesis and Evaluation of Haloacetyl, α-Bromoacryloyl and Nitrooxyacetyl Benzo[b]furan and Benzo[b]thiophene Derivatives as Potent Antiproliferative Agents Against Leukemia L1210 and K562 Cells
Letters in Drug Design & Discovery Association of Metronidazole with Cancer: A Potential Risk Factor or Inconsistent Deductions?
Current Drug Metabolism Use of Intravenous Immunoglobulin in the Treatment of Immune-Mediated Demyelinating Diseases of the Nervous System
Current Pharmaceutical Design Recent Developments in the Third Generation Inhibitors of Bcr-Abl for Overriding T315I Mutation
Current Medicinal Chemistry Resistance to Imatinib in Chronic Myeloid Leukemia and Therapeutic Approaches to Circumvent the Problem
Cardiovascular & Hematological Disorders-Drug Targets A New Era of Pulmonary Delivery of Nano-antimicrobial Therapeutics to Treat Chronic Pulmonary Infections
Current Pharmaceutical Design Sphere Formation Assay is not an Effective Method for Cancer Stem Cell Derivation and Characterization from the Caco-2 Colorectal Cell Line
Current Stem Cell Research & Therapy Inhibitors of HDACs - Effective Drugs Against Cancer?
Current Cancer Drug Targets